(Bloomberg) -- Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made ...
Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines the two countries refused to take delivery of during the pandemic, handing ...
Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a ...
A Wisconsin federal district court denied Pfizer’s motion to compel arbitration in an ADA case brought by a temporary warehouse associate with a prescription for oxycodone, ruling Pfizer couldn’t ...
Recon: US signs $3.2B deal for Pfizer-BioNTech vaccines; Novartis said to lean toward spinoff of generics unit Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results